Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Medtronic PLC    MDT   IE00BTN1Y115

MEDTRONIC PLC

(MDT)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Medtronic : 4Q Profit Falls on Higher Expenses, Restructuring Charge

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/23/2019 | 07:52am EDT

By Kimberly Chin

Medtronic PLC (MDT) said profit fell in the fourth quarter after it recorded slightly higher expenses and an $86 million restructuring charge in the quarter, compared with $7 million a year earlier.

For the fiscal quarter ended April 26, the medical device company's net income was $1.17 billion, or 87 cents a share, compared with $1.46 billion, or $1.07 a share, from a year ago. Analysts polled by Refinitiv were expecting $1.15 a share.

Excluding special items, Medtronic made an adjusted profit of $1.54 a share. Analysts forecasted $1.46 a share.

Sales were flat from a year ago, at $8.15 billion. Analysts expected $8.11 billion. U.S. revenue, which represents over half of Medtronic's total revenues, rose 2.3%, to $4.28 billion, from the same period last year.

Write to Kimberly Chin at kimberly.chin@wsj.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDTRONIC PLC
06/11MEDTRONIC : Real-World Data from Guardian Connect and Sugar.IQ Reveal Improved D..
AQ
06/11MEDTRONIC : Announces Its Forthcoming Robotic Assisted Surgical Platform to Feat..
AQ
06/10MEDTRONIC : Real-World Data from Guardian(TM) Connect and Sugar.IQ(TM) Reveal Im..
AQ
06/10MEDTRONIC : Initiates Pivotal Trial for Next-Generation Guardian Continuous Gluc..
AQ
06/10MEDTRONIC : Initiates Pivotal Trial for Bluetooth Enabled MiniMed 780G Advanced ..
AQ
06/10MEDTRONIC : and Tidepool Work Together on Interoperable Automated Insulin Pump S..
AQ
06/10MEDTRONIC : and Tidepool Work Together on Interoperable Automated Insulin Pump S..
AQ
06/10MEDTRONIC : Announces Its Forthcoming Robotic Assisted Surgical Platform to Feat..
AQ
06/08MEDTRONIC : Initiates Pivotal Trial for Next-Generation Guardian(TM) Continuous ..
AQ
06/08MEDTRONIC : Initiates Pivotal Trial for Bluetooth Enabled MiniMed(TM) 780G Advan..
AQ
More news
Financials ($)
Sales 2020 31 415 M
EBIT 2020 9 226 M
Net income 2020 5 918 M
Debt 2020 16 092 M
Yield 2020 2,18%
P/E ratio 2020 23,41
P/E ratio 2021 20,15
EV / Sales 2020 4,66x
EV / Sales 2021 4,35x
Capitalization 130 B
Chart MEDTRONIC PLC
Duration : Period :
Medtronic PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 103 $
Spread / Average Target 6,2%
EPS Revisions
Managers
NameTitle
Omar S. Ishrak Chairman & Chief Executive Officer
Mark Ploof Senior Vice President-Global Operations
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Richard E. Kuntz Chief Scientific, Clinical & Regulatory Officer
Richard H. Anderson Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MEDTRONIC PLC7.19%125 127
BAXTER INTERNATIONAL INC.18.40%37 732
HOYA CORPORATION24.56%26 026
ZIMMER BIOMET HOLDINGS13.24%23 408
ALIGN TECHNOLOGY45.97%22 667
TERUMO CORP-47.40%21 458